Commercial Deliverability & Academic Collaboration

Join us at the North American Adoptive T-Cell Therapy Congress, which gathers thought leaders from biotech, big pharma, academia and the wider service community to discuss progress and share insight on strategies – including Car-T, TILS and TCR – that are critical to furthering the development of viable T-cell therapies.

Key session topics include Advancements in T-cell engineering, efficacy in different cancer models, results from human and clinical studies, commercialisation of Viable T-cell therapies and scaling and manufacture of T-cells.
View the agenda >>

2016 Featured Speakers

Participating Organizations

TxCell-banniere-en-v2UPennlogo2University_of_Chicago_logo.svgUniversity of cologne logoMSKCC_logo
adaptimmune-logoBaylor_College_of_Medicine_LogoBellicumcardiffCellular Therapueticslogo

2016 Media Partners:

BioProcess InternationalCellTherapyNewsgenetherapynetbanner234x60 - gif
Human Gene Therapy logoIMT-logoHumanImmunologyNews
ImmuneRegulationNewsMNT Logo 2016Drug taget review Logo-01

Who You Will Meet?

Heads of Lab, Clinicians, Scientists and Industry Professionals are attending in order to build a career-changing network for their business and personal growth. Here’s a quick snapshot of their background:

Audience Profile

  • Clinical Investigators
  • Professors
  • Research Scientists
  • Heads of Lab
  • Graduate Students
    /Post-Doctoral Fellows
  • Research Institutes

Vendor Profiles

  • Biotechnology
  • Regulatory Scientists
  • Consultants
  • Cloud Chain
  • R&D Organisations
  • Technology Providers